CIK 0001840439
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 4,273 shares (grant or award)
- 4 Open-market sale 10% owner sold 125,000 shares at an average $34.11 ($4,263,915)
- 4 Open-market sale 10% owner sold 25,000 shares at $33.84 ($846,000)
- 4 Open-market sale 10% owner sold 250,000 shares at an average $34.30 ($8,575,030)
- 4 Open-market sale 10% owner sold 200,000 shares at $29.12 ($5,823,760)
- 4/A Open-market sale 10% owner sold 200,000 shares at $31.25 ($6,250,000)
- 4 Open-market sale 10% owner sold 200,000 shares at $31.25 ($6,250,000)
- 4 Open-market buy Director bought 400,000 shares at $30.00 ($12,000,000)
- 5 Insider Annual Insider Trading Report
- 4/A Open-market buy President and COO bought 8,400 shares at $17.00 ($142,800)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 2,518 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $7.93 ($39,650)
- 4 Open-market buy Chief Financial Officer bought 4,100 shares at $7.63 ($31,286)
- 4 Open-market buy 10% owner bought 30,684 shares at $13.87 ($425,648)
- 4 Open-market sale 10% owner sold 34,658 shares at $11.21 ($388,516)
Page 3 of 5 · 98 filings